Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESTHER trial of etanercept versus sulfasalazine in early axial spondyloarthritis
2005-002320-34Phase 2Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- May 2006
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in axial spondyloarthritis (axSpA) comparing Etanercept + NSAIDs with Sulfasalazine + NSAIDs (2 arms). Started May 2006; status: completed.
02
Drugs
etanercept5-aminosalicylic acid + sulphasalazine
03
Conditions
axial spondyloarthritis (axSpA)
Beyond the preview
Go deeper on 2005-002320-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002320-34.